Experimental models and their use in studies of diabetic retinal microangiopathy.
Diabetes produces dramatic changes in retinal microvasculature, triggering endothelial cell proliferation and microaneurysms. Capillaries become weakened, releasing blood into vitreal and retinal spaces. Photoreceptors become occluded and separated from the choriocapillaris, resulting in visual acuity decline, detachment and cell death. Several models have been developed that have proved useful for the study of this disease, resulting in a better understanding of the processes involved. Streptozotocin treatment affects the pancreatic beta cells, rapidly reducing them until insulin is no longer synthesized in sufficient amounts. The galactosemic model shifts metabolism away from glucose, increasing aldose reductase and retinal polyol metabolism. Finally, two weeks of cycled oxygen from high to low tension every 24 hours, followed by return to room air, triggers microangiogenesis in developing retinas. Use of these models, separately or in combination, as well as electroretinographic analysis, has begun to reveal the events taking place as diabetic retinopathy progresses. Endothelial cells become separated from pericytes as basement membranes thicken, and vascular endothelial growth factor increases, triggering their proliferation. Finally, early changes occurring within photoreceptors can now be studied.
Bazan
N G
NG
Louisiana State University Medical Center, Neuroscience Center of Excellence, New Orleans 70112, USA.
Gordon
W C
WC
Marcheselli
V L
VL
Lukiw
W J
WJ
Duhault
J
J
Koenig-Berard
E
E
Linn
D M
DM
DeCoster
M A
MA
Mukherjee
P K
PK
D000818:Animals; D000900:Anti-Bacterial Agents; D003921:Diabetes Mellitus, Experimental; D003930:Diabetic Retinopathy / Q000139:chemically induced / Q000209:etiology*; D004195:Disease Models, Animal; D005693:Galactosemias / Q000150:complications; D010100:Oxygen / Q000008:administration & dosage / Q000494:pharmacology; D013311:Streptozocin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D013311:Streptozocin; D010100:Oxygen